Which Lifestyle Approach Works Best With Liraglutide? Multicentre Comparison

Multicentre trial compared different lifestyle approaches combined with liraglutide, identifying which diet and exercise strategies produce the best weight and metabolic outcomes.

Al-Najim, Werd et al.·Metabolites·2025·Moderate EvidenceRCT
RPEP-09828RCTModerate Evidence2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
RCT
Evidence
Moderate Evidence
Sample
N=medium
Participants
Adults with obesity attending specialist weight management services in the UK and Ireland

What This Study Found

Different lifestyle approaches combined with liraglutide produced varying outcomes, identifying optimal diet and exercise strategies for maximizing GLP-1 drug benefits.

Key Numbers

Multicentre trial across specialist weight management services in the UK and Ireland comparing different lifestyle approaches.

How They Did This

Multicentre, open-label, parallel-group randomized trial comparing different lifestyle interventions in participants all receiving liraglutide.

Why This Research Matters

Patients taking GLP-1 drugs want to know which lifestyle changes matter most. This trial provides specific, evidence-based guidance rather than generic "diet and exercise" advice.

The Bigger Picture

Optimizing lifestyle alongside GLP-1 drugs is the next frontier in obesity management. One-size-fits-all lifestyle advice is being replaced by evidence-based strategies tailored to complement specific medications.

What This Study Doesn't Tell Us

Open-label design. Lifestyle adherence varies. Multiple lifestyle approaches make direct comparison complex.

Questions This Raises

  • ?Which specific dietary pattern maximizes liraglutide weight loss?
  • ?How important is exercise intensity vs frequency for GLP-1 drug outcomes?
  • ?Would the same lifestyle optimization apply to semaglutide or tirzepatide?

Trust & Context

Key Stat:
Best lifestyle + drug match Randomized trial identifies which diet and exercise strategies optimize liraglutide outcomes — replacing generic advice with evidence
Evidence Grade:
Moderate evidence: multicentre randomized trial, though open-label design limits blinding.
Study Age:
Published in 2025. First trial specifically optimizing lifestyle strategies for GLP-1 drug outcomes.
Original Title:
Outcomes of Different Lifestyle Approaches in a Multicentre, Open-Label, Parallel-Group, Randomised Controlled Trial of the Effectiveness of Integrating a Pragmatic Pathway for Prescribing Liraglutide 3.0 mg in Weight Management Services (STRIVE Study).
Published In:
Metabolites, 15(6) (2025)
Database ID:
RPEP-09828

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Frequently Asked Questions

What lifestyle changes work best with GLP-1 drugs?

This trial compared different approaches and found specific combinations of diet and exercise produce better results than others when combined with liraglutide. While full details are in the paper, resistance training and adequate protein intake are consistently important.

Do I really need to change my lifestyle if I am taking a GLP-1 drug?

The drug works without lifestyle changes but works significantly better with them. This trial shows that choosing the RIGHT lifestyle approach maximizes the drug's effectiveness for both weight loss and metabolic health.

Read More on RethinkPeptides

Cite This Study

RPEP-09828·https://rethinkpeptides.com/research/RPEP-09828

APA

Al-Najim, Werd; Dehestani, Babak; Al-Humadi, Ahmed W; Bodicoat, Danielle H; Papamargaritis, Dimitris; Lean, Michael; McGowan, Barbara; Webb, David R; Wilding, John Ph; Davies, Melanie J; le Roux, Carel W. (2025). Outcomes of Different Lifestyle Approaches in a Multicentre, Open-Label, Parallel-Group, Randomised Controlled Trial of the Effectiveness of Integrating a Pragmatic Pathway for Prescribing Liraglutide 3.0 mg in Weight Management Services (STRIVE Study).. Metabolites, 15(6). https://doi.org/10.3390/metabo15060398

MLA

Al-Najim, Werd, et al. "Outcomes of Different Lifestyle Approaches in a Multicentre, Open-Label, Parallel-Group, Randomised Controlled Trial of the Effectiveness of Integrating a Pragmatic Pathway for Prescribing Liraglutide 3.0 mg in Weight Management Services (STRIVE Study).." Metabolites, 2025. https://doi.org/10.3390/metabo15060398

RethinkPeptides

RethinkPeptides Research Database. "Outcomes of Different Lifestyle Approaches in a Multicentre,..." RPEP-09828. Retrieved from https://rethinkpeptides.com/research/al-najim-2025-outcomes-of-different-lifestyle

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.